$1.160.87%0.01

Pre-mercato: 1.19+0.03 +2.59%

Bionano Genomics Inc (BNGO)

Date: O: H: L: C: Vol:

Precedente Chiudi:

Volume 24 ore:

Volume relativo:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1W Prestazione:

1M Prestazione:

6M Prestazione:

1Y Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Profilo aziendale di Bionano Genomics Inc (BNGO)

Bionano Genomics Inc

(858) 888-7600

9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA, USA

Prossima data di guadagno

Ultimi documenti SEC

Discussioni di BNGO su X

Bionano Genomics Inc Azioni (BNGO) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2024-11-15	Downgrade	Ladenburg Thalmann	Buy → Neutral
2024-09-10	Downgrade	BTIG Research	Buy → Neutral
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-12-12	Resumed	BTIG Research	Buy
2022-07-18	Resumed	Oppenheimer	Outperform
2021-06-16	Iniziato	BTIG Research	Buy
2020-09-24	Iniziato	Ladenburg Thalmann	Buy
2020-04-08	Iniziato	Oppenheimer	Outperform

Bionano Genomics Inc Azioni (BNGO) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	28.51	30.78	36.12	27.80	17.98
Cost of revenue USD (M)	15.32	30.40	26.55	21.86	14.11
Gross profit USD (M)	-	-	9.57	5.95	3.87
Research and development USD (M)	11.37	24.80	54.03	49.05	22.49
Operating expenses USD (M)	46.52	104.36	224.81	137.64	80.98
Operating income USD (M)	-33.34	-103.98	-215.25	-131.70	-77.10
Income before tax USD (M)	-26.33	-111.98	-232.43	-130.71	-78.15
Income tax expense USD (M)	0.07	0.03	0.06	1.88	-5.72
Net income USD (M)	-26.40	-112.02	-232.49	-132.60	-72.44
Basic EPS USD/shares	-4.85	-88.13	-6.81	-0.46	-
Diluted EPS USD/shares	-4.85	-88.13	-6.81	-0.46	-
Basic weighted shares shares (M)	5.45	1.27	34.15	289.21	-
Diluted weighted shares shares (M)	5.45	1.27	34.15	289.21	-
Selling, general and administrative USD (M)	35.15	51.86	93.50	88.60	58.49

Bionano Genomics Inc Azioni (BNGO) insider trading

Luderer AlbertSep 04 '26
Interim Chief Executive
Transazione
Buy
Costo
$1.21
#Azioni
4,000
Valore ($)
4,845
#Azioni Totale
8,000
Luderer AlbertAug 21 '26
Interim Chief Executive
Transazione
Buy
Costo
$1.22
#Azioni
4,000
Valore ($)
4,860
#Azioni Totale
4,000

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Luderer Albert	Interim Chief Executive	Sep 04 '26	Buy	$1.21	4,000	4,845	8,000
Luderer Albert	Interim Chief Executive	Aug 21 '26	Buy	$1.22	4,000	4,860	4,000

Bionano Genomics Inc Borsa (BNGO) Ultime notizie

Bionano Genomics Inc (BNGO)

Profilo aziendale di Bionano Genomics Inc (BNGO)

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Bionano Genomics Inc Azioni (BNGO) Upgrade e downgrade

Bionano Genomics Inc Azioni (BNGO) Dati Finanziari

Bionano Genomics Inc Azioni (BNGO) insider trading

Bionano Genomics Inc Borsa (BNGO) Ultime notizie

Needing capital in the very near term, Bionano Genomics (BNGO) amends its offering plan. - Stock Titan

Form S-1 Bionano Genomics Inc For: 27 October By Investing.com - Investing.com South Africa

Form S-1 Bionano Genomics Inc For: 27 October By Investing.com - Investing.com Canada

Form S-1 Bionano Genomics Inc For: 27 October By Investing.com - Investing.com UK

Is the New Setup at Bionano Genomics (NASDAQ:BNGO) Sustainable? - Kalkine Media

Viking Therapeutics plans $400M stock and conve... - Pluang

Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance Singapore

Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance UK

Why Is Bionano Genomics (NASDAQ:BNGO) Standing Out as Traders Parse Sector Signals and Macro Pressure? - Kalkine Media

Why Has Bionano Genomics (BNGO) Returned to the Spotlight? - Kalkine Media

Form 8K Bionano Genomics Inc For: 14 September By Investing.com - Investing.com UK

Local Coverage Determinations Roundup: ChromaCode, Biofidelity, Biocartis, Bionano Genomics - GenomeWeb

MolDX proposes Medicare coverage for Bionano genome mapping test - Investing.com

MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Canada

Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - The Manila Times

Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - marketscreener.com

MolDX proposes Medicare coverage for Bionano genome mapping test By Investing.com - Investing.com Nigeria

Bionano Genomics (NasdaqCM:BNGO) Stock Forecast & Analyst Predictions - Simply Wall Street

Bionano Genomics (BNGO) interim CEO adds 4,000 shares in IRA - Stock Titan

Bionano Laboratories Announces New York State Department of - GlobeNewswire

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Moomoo

Bionano Genomics (NASDAQ:BNGO) Shares Turns Active on Today’s Market Trigger - Kalkine Media

Bionano Genomics Inc. Warrant (BNGOW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Bionano Genomics Inc. Warrant (BNGOW) Peer Comparison – Compare with Others - Value Research

Bionano Genomics Inc. Warrant (BNGOW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Bionano Genomics Inc. Warrant (BNGOW) Key Financial Ratios – Valuation, Profitability & More - Value Research

Bionano Genomics Inc. (BNGO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Bionano Genomics Inc. (BNGO) Peer Comparison – Compare with Others - Value Research

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Barchart.com

Bionano Genomics (NASDAQ: BNGO) interim CEO buys 4,000 shares - Stock Titan

Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest Trading - Long-Term Guidance - vinanet.vn

Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - qz.com

Bionano Genomics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - AOL.com

Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - The Globe and Mail

Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - The Globe and Mail

Alex Reid Hastie Net Worth (2026) - GuruFocus

Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan

Gossamer Bio: Q2 Earnings Snapshot - AOL.com

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail

Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo

Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo

Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria

Bionano Genomics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha

Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat

Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus

Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus

Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada

Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Canada

Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Simile a BNGO